# DESCRIPTION

## FIELD

- relate to medicine and biology

## BACKGROUND

- describe dengue disease and its effects

## SUMMARY

- introduce ubiquitin-proteasome pathway in dengue virus infection
- describe method of diagnosis or prognosis of dengue
- describe method of treatment or prevention of dengue
- describe method of identifying a molecule suitable for treatment of dengue
- describe use of polynucleotide for method of diagnosis or treatment
- describe method of identifying an agonist or antagonist of ubiquitin-proteasome pathway protein

## DETAILED DESCRIPTION

- identify dengue diagnostic targets
- describe dengue detection methods
- outline dengue treatment approaches
- discuss dengue prevention strategies

### Dengue

- define dengue disease

### Assays for Dengue

- describe plaque assay for dengue

### Ubiquitin-Proteasome Pathway

- define ubiquitin-proteasome pathway
- describe ubiquitin structure and function
- outline ubiquitinylation process
- explain proteasome structure and function
- discuss proteasome inhibitors
- introduce ubiquitin-proteasome pathway proteins

### Screening Assays

- employ ubiquitin-proteasome pathway protein in screening process
- use rational design to identify candidate compounds
- screen candidate compounds using phage display techniques
- utilize eukaryotic or prokaryotic host cells for screening
- conduct competitive assays to detect binding affinity
- use solubilized, unpurified or solubilized purified polypeptide for molecular binding assay
- configure assays to detect effect of added compounds on production of mRNA and protein in cells

### Variants and Functional Equivalents of ALLN and MG-132

- provide chemical derivatives of ALLN and MG-132
- describe substituted variants of ALLN and MG-132
- discuss pharmaceutically acceptable salts of ALLN and MG-132
- cover polymorphic forms, isotopic variations, prodrugs, and salts of ALLN and MG-132

### Pharmaceutical Compositions

- describe pharmaceutical compositions for treating dengue
- outline administration routes and modes
- list suitable pharmaceutically acceptable excipients
- describe pharmaceutical compositions in various forms
- outline methods for inhibiting ubiquitin-proteasome pathway proteins
- describe methods for treating dengue
- define effective amounts of inhibitors, agonists, or antagonists
- outline liposome administration
- describe combination therapy with other agents
- discuss bioavailability of compounds

### Other Uses

- develop therapeutic treatments for dengue
- diagnose dengue using immunoassay dipstick test

### Examples

- identify host factors involved in dengue replication
- inhibit viral replication by compounds affecting ubiquitin-proteasome pathway
- analyze concentration dependent effect of compounds on dengue viral production
- confirm ubiquitin pathway activation in second cell line and patients with dengue
- describe methods for cell culture, virus culture, infection, and assaying
- describe microarray experiment
- select differentially expressed genes using SAM
- perform pathway detection using Panther
- analyze expression using TaqMan Low Density Array (TLDA)
- identify common up-regulated genes across systems
- analyze specific genes and their roles in dengue infection

